OnQuality Pharmaceuticals just raised $20 million in Series A+ funding to support its Phase II oncodermatology trial. The trial assesses the safety and efficacy of a targeted supportive care agent that addresses the specific side effects of vascular endothelial growth factor receptor (VEGFR) inhibitors among cancer patients. The lead candidate, OQL011, is topical ointment and […]

There are historic advances to applaud in the fight against COVID-19. Vaccines are rolling out, and people are getting shots at a rate of more than 2 million a day. The vaccines cleared for Emergency Use Authorization by the Food and Drug Administration are protecting people from serious disease, and it appears they can quell […]

Scott Storrer, CEO of Affinity Empowering, Inc., and Dr. Michael Tkach, Chief Operating Officer and Chief Behavioral Health Officer of Affinity Empowering, Inc., discuss the launch of the COVID Clinic™ service around the country. Affinity is partnering with retail stores nationwide, placing 20’ x 8’ full-service COVID support stations in parking lots within local communities. […]